🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Avanthika Venkatachalam

Massachusetts General Hospital

ORCID: 0000-0001-9429-0659

Also affiliated with Center for Cancer Research

MedicineChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AML”.

Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AML

Journal of Hematology & Oncology(2025)10.1186/s13045-025-01724-z
N/A
0.254DataRank · unranked
4 citations

Wenbin Xiao, Gautam Borthakur, Le Xuan Truong Nguyen, Melissa Valerio, Avanthika Venkatachalam +11 more

Melanin-Driven Delayed CPD Formation Is Independent of Melanin Biosynthesis Pathway

Journal of Investigative Dermatology(2025)10.1016/j.jid.2025.09.011
N/A
0.104DataRank · unranked
1 citations

Jyoti Srivastava, Avanthika Venkatachalam, Mukund P. Tantak, Nicholas J. Lawrence, David E. Fisher +3 more

Phase I First-in-Human Dose Escalation Study of the oral Casein Kinase 1α and Cyclin Dependent Kinase 7/9 inhibitor BTX-A51 in advanced MDS and AML

Research Square(2024)10.21203/rs.3.rs-4954060/v1
N/A
0DataRank · unranked
0 citations

Wenbin Xiao, Gautam Borthakur, Le Xuan Truong Nguyen, Melissa Valerio, Avanthika Venkatachalam +11 more